Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-50
Closed -$2.76K 129
2019
Q4
$2.76K Hold
50
﹤0.01% 112
2019
Q3
$2.29K Hold
50
﹤0.01% 112
2019
Q2
$2.16K Hold
50
﹤0.01% 111
2019
Q1
$2.17K Hold
50
﹤0.01% 113
2018
Q4
$2.36K Hold
50
﹤0.01% 117
2018
Q3
$3.73K Hold
50
﹤0.01% 115
2018
Q2
$2.76K Hold
50
﹤0.01% 118
2018
Q1
$1.9K Hold
50
﹤0.01% 111
2017
Q4
$1.4K Hold
50
﹤0.01% 107
2017
Q3
$1.55K Hold
50
﹤0.01% 110
2017
Q2
$1.41K Buy
+50
New +$1.21K ﹤0.01% 116

Other funds holding SRDX

GS Investments's SRDX Position: Q1 2020 in Review

GS Investments sold out of Surmodics (SRDX) in Q1 2020, closing a stake of 50 shares — an estimated $2.76K sold.

GS Investments first reported a position in SRDX in Q2 2017 and held it in 11 quarters. The position peaked at $3.73K in Q3 2018. 127 funds tracked by Wall St. Rank hold SRDX as of Q1 2020.

  • GS Investments reported no remaining Surmodics position as of Q1 2020 after selling out during the quarter.
  • GS Investments sold 50 Surmodics shares in Q1 2020, an estimated $2.76K.
  • GS Investments first reported a position in Surmodics in Q2 2017 and held it in 11 quarters.
  • GS Investments's Surmodics position peaked at $3.73K in Q3 2018.
  • 127 funds tracked by Wall St. Rank held Surmodics as of Q1 2020.

Based on GS Investments's 13F filing for Q1 2020, filed 7 May 2020.